Publication Tracker — ASH
Live timeline of 9766 PMID-verified articles ASH tracks. Filter by category to explore the literature growth toward our 10,000-paper coverage goal.
This page is the public face of ASH's literature-tracking pipeline. Every entry here is parsed from PubMed metadata directly, cross-checked against the article's real PMID, and committed into the open-source registry behind this site. Hand-curated registries are tracked separately at PMID Audit Status.
The corpus grows continuously as new PubMed-indexed hirudotherapy and leech-derived-compound papers are published. The 10,000-article goal is the coverage threshold needed to consider ASH's literature surveillance comprehensive across all leech-related biomedical sub-fields.
9766
Total tracked articles
PMID-verified, auto-imported from PubMed
1767
Added in last 12 months
Rolling window ending 2026-05-27
97.7%
Progress toward 10,000-paper goal
Filter by category
Showing 3192 articles in Drug Development. Clear filter
Timeline by publication year
2026
140 articlesCurrent yearComparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial
Zhang et al. · Lupus science & medicine
Added to ASH registry: 2026-05-29
Dabigatran outperforms warfarin in elderly patients with atrial fibrillation and stable coronary artery disease: reduced risks of bleeding and cardiovascular events
Song et al. · American journal of translational research
Added to ASH registry: 2026-05-29
Dabigatran-induced acute hepatitis in a patient with atrial fibrillation: a rare case report
Hsu et al. · European heart journal. Case reports
Added to ASH registry: 2026-05-29
Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study
Guo et al. · Frontiers in pharmacology
Added to ASH registry: 2026-05-29
Edoxaban for stroke prevention in patients with atrial fibrillation: Of randomized and real-world evidence
de · Indian pacing and electrophysiology journal
Added to ASH registry: 2026-05-29
Edoxaban-induced enterocolitis: The first case report demonstrating distinct endoscopic and histological features
Endo et al. · DEN open
Added to ASH registry: 2026-05-29
Efficacy and safety of reduced-dose versus full-dose DOACs in extended treatment of VTE: A systematic review and meta-analysis
Bilal et al. · Journal of thrombosis and thrombolysis
Added to ASH registry: 2026-05-29
Efficacy of argatroban plus alteplase versus intravenous alteplase according to diabetes mellitus in acute ischemic stroke
Hou et al. · Scientific reports
Added to ASH registry: 2026-05-29
Extended Rivaroxaban Therapy for Cancer-Associated Low-Risk Pulmonary Embolism by Chemotherapy Status: Insights from the ONCO PE Trial
Xiong et al. · Thrombosis and haemostasis
Added to ASH registry: 2026-05-29
Peak and Trough Concentration Ranges of Factor Xa Inhibitors for Preventing Thromboembolic Stroke in Korean Patients with Non-valvular Atrial Fibrillation
Park et al. · Annals of laboratory medicine
Added to ASH registry: 2026-05-29
Pharmacogenomic profiling of ABCB1 and CES1 in atrial fibrillation patients on dabigatran from a multiethnic Malaysian cohort
Tan et al. · Scientific reports
Added to ASH registry: 2026-05-29
Real-World Edoxaban Concentrations in Older Patients Receiving Reduced-Dose Regimens
Tang et al. · Clinical pharmacology and therapeutics
Added to ASH registry: 2026-05-29
Reversal of Progressive In-Hospital Posterior Artery-to-Artery Embolic Stroke With Argatroban: A Case Report
She et al. · British journal of hospital medicine (London, England : 2005)
Added to ASH registry: 2026-05-29
Total Clinical Event Burden with Edoxaban Monotherapy versus Dual Antithrombotic Therapy in Atrial Fibrillation and Stable Coronary Artery Disease: Insights from the EPIC-CAD Trial
Kim et al. · Journal of the American Heart Association
Added to ASH registry: 2026-05-29
A comprehensive multicenter study assessing the impact of abelacimab, asundexian and milvexian on coagulation assays
Goubeau et al. · Blood advances
Added to ASH registry: 2026-05-28
A heparin-functionalized scaffold loaded with pleiotrophin enhances endothelialization and angiogenic potential in liver tissue engineering
Yadav CJ et al. · Biomaterials science
Added to ASH registry: 2026-05-28
A Thorough QT Study to Assess the Effects of Milvexian on Cardiac Repolarization in Healthy Participants
Zannikos et al. · Clinical pharmacology in drug development
Added to ASH registry: 2026-05-28
Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 Trial
Al Said et al. · JAMA cardiology
Added to ASH registry: 2026-05-28
Acute unintentional single-substance pediatric exposures to direct factor Xa inhibitors reported to US Poison Centers, 2011-2019
Kolbeck M et al. · Clinical toxicology (Philadelphia, Pa.)
Added to ASH registry: 2026-05-28
Advancing Point-of-Care Analysis: The Future of Thromboelastographic DOAC-Detection: A Systematic Review
Herpertz GU et al. · Seminars in thrombosis and hemostasis
Added to ASH registry: 2026-05-28
Andexanet alfa for the reversal of anticoagulation: Dutch practice data
Krommenhoek JF et al. · Research and practice in thrombosis and haemostasis
Added to ASH registry: 2026-05-28
Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation
Lu et al. · American journal of kidney diseases : the official journal of the National Kidney Foundation
Added to ASH registry: 2026-05-28
Association of Edoxaban Pharmacokinetics With Bleeding in Older Patients With Atrial Fibrillation Treated With Low-Dose Edoxaban: A Post Hoc Analysis of a Randomized Controlled Trial
Okumura K et al. · Journal of the American Heart Association
Added to ASH registry: 2026-05-28
Automated Thromboelastometry for Semiquantitative Assessment of High Heparin Concentrations: A Feasibility Study in Healthy Volunteers
Pada et al. · Health science reports
Added to ASH registry: 2026-05-28
Bioinspired apixaban nanosuspension-loaded polymeric microneedle arrays for non-invasive transdermal delivery: a skin-friendly patch
Abdel-Messih HA et al. · European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Added to ASH registry: 2026-05-28
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
Castellucci LA et al. · The New England journal of medicine
Added to ASH registry: 2026-05-28
Cancer-Associated Stroke Complicated by Heparin-Induced Thrombocytopenia: A case report.
Okada T et al. · Internal medicine (Tokyo, Japan)
Added to ASH registry: 2026-05-28
Caught in Transit: Mobile Right Atrial Thrombus in Intermediate-High-Risk Pulmonary Embolism Treated With Half-Dose Alteplase
Gomaa et al. · The American journal of case reports
Added to ASH registry: 2026-05-28
Combined Antithrombin and Heparin Supplementation to Blood for Restoring Heparin Responsiveness After Andexanet Alfa Exposure: An In Vitro Model
Butt et al. · EJHaem
Added to ASH registry: 2026-05-28
Comparative efficacy and safety of apixaban and rivaroxaban versus warfarin in atrial fibrillation patients with end-stage renal disease: a systematic review and meta-analysis
Wu X et al. · Renal failure
Added to ASH registry: 2026-05-28
Comparing anti-platelet and anti-thrombin therapies in the ischaemia-reperfusion injured coronary microcirculation of healthy and diabetic mice
Mitchell et al. · Basic research in cardiology
Added to ASH registry: 2026-05-28
Comparing Hemostatic Efficacy of Four-Factor Prothrombin Complex Concentrate with Andexanet Alfa in an Apixaban-Treated Polytrauma Male Porcine Model
Grottke et al. · Anesthesiology
Added to ASH registry: 2026-05-28
Delayed-type hypersensitivity to low-molecular-weight heparin and cross-reactivity to fondaparinux and danaparoid in a twin pregnancy
House et al. · Obstetric medicine
Added to ASH registry: 2026-05-28
Design and rationale of aspirin versus aspirin and fondaparinux prior to early invasive strategy in patients with NSTEMI: The FOXY trial
Fur et al. · American heart journal
Added to ASH registry: 2026-05-28
Design and rationale of the GUARD-OAC: A randomized controlled trial evaluating proton pump inhibitor cotherapy for gastrointestinal protection in patients requiring direct oral anticoagulants
Ahn HJ et al. · American heart journal
Added to ASH registry: 2026-05-28
Design, synthesis and biological evaluation of novel FXIa inhibitors featuring five-membered heterocycles as P2' fragments
Wu et al. · European journal of medicinal chemistry
Added to ASH registry: 2026-05-28
Development of an Oral Anticoagulation Strategy for Permanent Artificial Lung Support
Hong et al. · Transplantation
Added to ASH registry: 2026-05-28
Development of selective NBD-based fluorescent probes for in vitro detection of factor XIa and Thrombus imaging
Zhuang et al. · Bioorganic chemistry
Added to ASH registry: 2026-05-28
Direct Oral Anticoagulant Inhibitors: Mode of Action, Clinical Aspects
Hassan et al. · Handbook of experimental pharmacology
Added to ASH registry: 2026-05-28
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism in Hematologic Malignancies: A Comprehensive Review
Zhu Y et al. · European journal of haematology
Added to ASH registry: 2026-05-28
Showing 40 of 140. The full list is in the research library.
2025
297 articlesA Cost-Effectiveness Analysis of Rivaroxaban Compared to Warfarin for the Management of Venous Thromboembolism in Western Kenya
O'Neill et al. · Clinical drug investigation
Added to ASH registry: 2026-05-29
Administration of decapsulated dabigatran via nasogastric tube: A case report
Kaneta et al. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Added to ASH registry: 2026-05-29
Analysis of hemorrhagic transformation and intracerebral hemorrhage under combination therapy with alteplase and antiplatelets or anticoagulants, using the Japanese Adverse Drug Event Report database
Nakai et al. · PloS one
Added to ASH registry: 2026-05-29
Argatroban plus alteplase in posterior versus anterior circulation stroke
Cui et al. · Annals of clinical and translational neurology
Added to ASH registry: 2026-05-29
Argatroban plus dual antiplatelet therapy versus dual antiplatelet alone for acute atherothrombotic cerebral infarction
Nakashima et al. · International journal of stroke : official journal of the International Stroke Society
Added to ASH registry: 2026-05-29
Association Between Argatroban and Outcomes of Branch Atheromatous Disease: A Propensity-Matched Analysis From MRI-Based Study
Li et al. · CNS neuroscience & therapeutics
Added to ASH registry: 2026-05-29
Association of Genetic Variants With Rivaroxaban Pharmacokinetics and Pharmacodynamics and Hemorrhage Risk Factors in Patients With Venous Thromboembolism
Li et al. · Journal of the American Heart Association
Added to ASH registry: 2026-05-29
Biological Variation of Hemostasis Analytes in Atrial Fibrillation Patients Using Dabigatran
Tilly et al. · The journal of applied laboratory medicine
Added to ASH registry: 2026-05-29
Bleeding risk among cancer patients receiving concurrent CYP-interacting tyrosine kinase inhibitors with direct oral anticoagulants versus alternative anticoagulation therapies
Tan et al. · Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Added to ASH registry: 2026-05-29
Bleeding Risk in the Early Postoperative Period after Atrial Fibrillation Ablation with Anticoagulant Therapy Using Dabigatran Etexilate
Takashima et al. · Biological & pharmaceutical bulletin
Added to ASH registry: 2026-05-29
Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)
Anguita et al. · Expert review of cardiovascular therapy
Added to ASH registry: 2026-05-29
Dabigatran Attenuates the Binding of Thrombin to Platelets-A Novel Mechanism of Action
Lindahl et al. · Thrombosis and haemostasis
Added to ASH registry: 2026-05-29
Does direct oral anticoagulant lead-in dosing following initial parenteral therapy affect clinical outcomes in acute venous thromboembolism?: A retrospective cohort study
Kim et al. · International journal of clinical pharmacy
Added to ASH registry: 2026-05-29
Drug-drug interactions between epidermal growth factor receptor tyrosine kinase inhibitors and rivaroxaban in vitro and in vivo
Wang et al. · PloS one
Added to ASH registry: 2026-05-29
Edoxaban Monotherapy and Incidence of Transcatheter Heart Valve Leaflet Thrombosis - The Rotterdam Edoxaban (REDOX) Study
Adrichem et al. · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Added to ASH registry: 2026-05-29
Effect of Argatroban Plus Dual Antiplatelet in Branch Atherosclerosis Disease: A Randomized Clinical Trial
Xu et al. · Stroke
Added to ASH registry: 2026-05-29
Effectiveness and Safety of Dose-Specific DOACs in Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
Oh et al. · Cardiovascular therapeutics
Added to ASH registry: 2026-05-29
Effectiveness and Safety of Edoxaban in the Routine Clinical Care of Atrial Fibrillation Patients in Brazil: Prospective 1-Year Follow-Up Study - EdoBRA
Precoma et al. · Arquivos brasileiros de cardiologia
Added to ASH registry: 2026-05-29
Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries
Cepeda et al. · Frontiers in cardiovascular medicine
Added to ASH registry: 2026-05-29
Effects of Argatroban on Hcy, hs-CRP and FIB levels in patients with acute cerebral infarction
Yang et al. · The International journal of neuroscience
Added to ASH registry: 2026-05-29
Efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: A meta-analysis with trial sequential analysis and reconstructed time-to-event data
Ibrahim et al. · Thrombosis research
Added to ASH registry: 2026-05-29
Efficacy of antiplatelet drugs combined with Argatroban in treating acute ischemic stroke and its impact on patients' coagulation function and neurological function: a preliminary trial
Sun et al. · The International journal of neuroscience
Added to ASH registry: 2026-05-29
Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry
Vlazny et al. · Research and practice in thrombosis and haemostasis
Added to ASH registry: 2026-05-29
Impact of Factor Xa inhibitors on cardiovascular events in older patients with nonvalvular atrial fibrillation
Takahashi et al. · Aging
Added to ASH registry: 2026-05-29
Impact of weight/BMI on clinical and bleeding events in 26 805 atrial fibrillation patients on edoxaban from the Global ETNA-AF Registry
Boriani et al. · European journal of preventive cardiology
Added to ASH registry: 2026-05-29
In vivo Pharmacokinetic Interactions Between Palbociclib and Rivaroxaban or Apixaban: Implications for Increased Drug Exposure and Dose Adjustments
Du et al. · Drug design, development and therapy
Added to ASH registry: 2026-05-29
In Vivo pharmacokinetic interactions of ribociclib with rivaroxaban and apixaban in rats: implications for increased drug exposure and dose adjustments
Liu et al. · Frontiers in pharmacology
Added to ASH registry: 2026-05-29
Laboratory Measurement of Rivaroxaban in Patient with Cancer-Associated Thromboembolism; Focus on Initial Rivaroxaban Therapy
Yoon et al. · Clinical laboratory
Added to ASH registry: 2026-05-29
Literature-based case analysis of serious adverse drug events associated with edoxaban
Luan et al. · European journal of clinical pharmacology
Added to ASH registry: 2026-05-29
Low-dose direct oral anticoagulants for secondary prevention in patients at high risk for recurrence due to history of recurrent venous thromboembolic events or severe thrombophilia: a retrospective analysis of the Italian Survey on anTicoagulated pAtients RegisTry 2
Poli et al. · Journal of thrombosis and haemostasis : JTH
Added to ASH registry: 2026-05-29
Outcomes of Different Regimens of Rivaroxaban and Aspirin in Cardiovascular Diseases: A Network Meta-Analysis
Al-Salihi et al. · Journal of clinical medicine
Added to ASH registry: 2026-05-29
Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of Obesity
Menichelli et al. · Clinical pharmacokinetics
Added to ASH registry: 2026-05-29
Population pharmacokinetics of edoxaban in geriatric patients with atrial fibrillation
Edwina et al. · Journal of thrombosis and haemostasis : JTH
Added to ASH registry: 2026-05-29
Rivaroxaban for Venous Thromboembolism (VTE) in Paediatric Patients: An institutional retrospective observational study from the Low/Middle Income setting in Pakistan
Mahmood et al. · JPMA. The Journal of the Pakistan Medical Association
Added to ASH registry: 2026-05-29
Rivaroxaban Treatment in Pediatric Patients With Hematologic Malignancies and Venous Thromboembolism: A Report of Four Cases
Fukunaga et al. · Cureus
Added to ASH registry: 2026-05-29
Rivaroxaban versus low-molecular-weight heparins for short- and long-term prognosis in patients with deep vein thrombosis after spontaneous intracranial hemorrhage
Li et al. · Journal of comparative effectiveness research
Added to ASH registry: 2026-05-29
Rivaroxaban vs. enoxaparin for preventing venous thromboembolism after hip fracture operations: a retrospective cohort study
Zheng et al. · Frontiers in surgery
Added to ASH registry: 2026-05-29
Safety and efficacy of argatroban combined with antiplatelet therapy for acute mild-to-moderate ischemic stroke with large artery atherosclerosis
Yan et al. · Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Added to ASH registry: 2026-05-29
Screening thrombin inhibitors from Yangxinshi tablets by online capillary electrophoresis-based immobilized enzyme microreactor and molecular docking
Liu et al. · Phytochemical analysis : PCA
Added to ASH registry: 2026-05-29
Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus
Verheye et al. · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Added to ASH registry: 2026-05-29
Showing 40 of 297. The full list is in the research library.
2024
260 articlesA comparative study of the clinical benefits of rivaroxaban and dabigatran in patients with nonvalvular atrial fibrillation with high bleeding risk
Liu · Frontiers in cardiovascular medicine
Added to ASH registry: 2026-05-29
Adverse events of direct factor Xa inhibitors: a disproportionality analysis of the FAERS database
Qian et al. · Expert opinion on drug safety
Added to ASH registry: 2026-05-29
Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial
Navi et al. · JAMA neurology
Added to ASH registry: 2026-05-29
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation
Bergmark et al. · Circulation. Cardiovascular quality and outcomes
Added to ASH registry: 2026-05-29
Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand
Pongsathabordee et al. · Exploratory research in clinical and social pharmacy
Added to ASH registry: 2026-05-29
Argatroban Use in Pediatric Patients Supported by Paracorporeal Ventricular Assist Devices
Tuttle et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)
Added to ASH registry: 2026-05-29
Bivalirudin for unsalvageable venous congestion or obstruction in head and neck free flap reconstruction
Harris et al. · Oral oncology
Added to ASH registry: 2026-05-29
Bivalirudin Stability in Citrated Plasma and Citrated Whole Blood
Bruzdoski et al. · Archives of pathology & laboratory medicine
Added to ASH registry: 2026-05-29
Bivalirudin: The misunderstood alternative to heparin
Faraoni et al. · Paediatric anaesthesia
Added to ASH registry: 2026-05-29
Can the combination of antiplatelet or alteplase thrombolytic therapy with argatroban benefit patients suffering from acute stroke? a systematic review, meta-analysis, and meta-regression
Xie et al. · PloS one
Added to ASH registry: 2026-05-29
Clinical Implications of Co-administering Apixaban with Key Interacting Medications
Favatella et al. · Clinical pharmacology in drug development
Added to ASH registry: 2026-05-29
Comment on: Bivalirudin during thrombolysis with catheter-directed tPA in a heparin-refractory patient: A case report
Han · Pediatric blood & cancer
Added to ASH registry: 2026-05-29
Comparison of Apixaban, Rivaroxaban, Dabigatran, and Vitamin K Antagonists in Patients With Atrial Fibrillation and Liver Disease: A Network Meta-Analysis
Shaikh et al. · Cureus
Added to ASH registry: 2026-05-29
Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin
Kartika et al. · European journal of haematology
Added to ASH registry: 2026-05-29
Comparison of Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban in Patients With Valvular Atrial Fibrillation: A Network Meta-Analysis of Randomized-Control Trials and Observational Studies
Huma et al. · Cureus
Added to ASH registry: 2026-05-29
Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro
Gratz et al. · Scientific reports
Added to ASH registry: 2026-05-29
Drug-Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants
Hellfritzsch et al. · Seminars in thrombosis and hemostasis
Added to ASH registry: 2026-05-29
Editorial: Bivalirudin versus unfractionated heparin in acute myocardial infarction: Why are we still debating?
Cohen et al. · Cardiovascular revascularization medicine : including molecular interventions
Added to ASH registry: 2026-05-29
Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature
Borgonovo et al. · Cureus
Added to ASH registry: 2026-05-29
Esophageal Damage Following Left Atrial Ablation in a Patient on Dabigatran: Adding Insult to Injury
Jalloul et al. · European journal of case reports in internal medicine
Added to ASH registry: 2026-05-29
Heparin Resistance after Andexanet Alfa - Calling on Argatroban and Nafamostat for Rescue?
Mishima et al. · Journal of cardiothoracic and vascular anesthesia
Added to ASH registry: 2026-05-29
High-Dose Immunoglobulin Therapy for Multiple Thromboembolism in Persisting Heparin-Induced Thrombocytopenia
Kudo et al. · Cureus
Added to ASH registry: 2026-05-29
Intravenous thrombolysis following dabigatran reversal in a patient with acute embolic stroke after atrial fibrillation ablation
Chen et al. · Journal of arrhythmia
Added to ASH registry: 2026-05-29
L-shaped association between gamma-glutamyl transferase-to-albumin ratio and dabigatran-related bleeding in non-valvular atrial fibrillation patients: a multicenter cohort study
Yu et al. · Cardiovascular diagnosis and therapy
Added to ASH registry: 2026-05-29
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study
Kirchhof et al. · International journal of cardiology
Added to ASH registry: 2026-05-29
Management of Bivalirudin Dosing and Replacement Fluid During Therapeutic Plasma Exchange in Children on Extracorporeal Membrane Oxygenation
Chomat et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)
Added to ASH registry: 2026-05-29
Monitoring Argatroban Anticoagulation in the Critically Ill: All Tests Are Not Created Equal
Erdoes et al. · Anesthesiology
Added to ASH registry: 2026-05-29
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
Petch et al. · Scientific reports
Added to ASH registry: 2026-05-29
Population pharmacokinetics of unfractionated heparin and multivariable analysis of activated clotting time in patients undergoing radiofrequency ablation of atrial fibrillation
Konecki et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Added to ASH registry: 2026-05-29
Possible Factor Xa Resistance in a Patient Who Failed Apixaban and Rivaroxaban
Ali et al. · Clinical case reports
Added to ASH registry: 2026-05-29
Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma
Pei et al. · BMC biotechnology
Added to ASH registry: 2026-05-29
Smartphone App for Improving Self-Awareness of Adherence to Edoxaban Treatment in Patients With Atrial Fibrillation (ADHERE-App Trial): Randomized Controlled Trial
Yoon et al. · Journal of medical Internet research
Added to ASH registry: 2026-05-29
The effect of off-label use of reduced-dose direct oral anticoagulants therapy in the treatment of pulmonary embolism comparable to standard-dose therapy
Yamazoe et al. · Heart and vessels
Added to ASH registry: 2026-05-29
UGT2B15 single nucleotide polymorphism reduces dabigatran acylglucuronide formation in humans
Park et al. · Frontiers in pharmacology
Added to ASH registry: 2026-05-29
Unresponsiveness of Activated Partial Thromboplastin Time to Bivalirudin in Adults Receiving Extracorporeal Membrane Oxygenation
Jatis et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)
Added to ASH registry: 2026-05-29
Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series
Halawi et al. · Pharmacotherapy
Added to ASH registry: 2026-05-29
5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.
Lakkireddy D et al. · Journal of the American College of Cardiology
Added to ASH registry: 2026-05-28
A Comparison Between Fondaparinux Sodium and Low-Molecular-Weight Heparin in Preventing Patients Undergoing Hip Replacement from Deep Vein Thrombosis
Wang et al. · Journal of musculoskeletal & neuronal interactions
Added to ASH registry: 2026-05-28
A narrative review of acute pancreatitis-induced splanchnic vein thrombosis: from pathogenesis to clinical management.
Liu et al. · Scandinavian journal of gastroenterology
Added to ASH registry: 2026-05-28
A pharmacokinetic and pharmacodynamic evaluation of asundexian: a novel factor XIa inhibitor for stroke prevention
Cella et al. · Expert opinion on drug metabolism & toxicology
Added to ASH registry: 2026-05-28
Showing 40 of 260. The full list is in the research library.
2023
199 articlesA BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction
Vergallo et al. · European heart journal
Added to ASH registry: 2026-05-29
Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation
Seelhammer et al. · Critical care medicine
Added to ASH registry: 2026-05-29
Anti-thrombotic Therapy With Cangrelor and Bivalirudin in Venoarterial Extracorporeal Membrane Oxygenation Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Experience
Baldetti et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)
Added to ASH registry: 2026-05-29
Anticoagulation Stability With Bivalirudin: Positioning the Horse Before the Cart
Chen et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)
Added to ASH registry: 2026-05-29
Apixaban at Apex? Aligning Drug Pricing With Value in Cancer-Associated Thrombosis
Ito et al. · Annals of internal medicine
Added to ASH registry: 2026-05-29
Bivalirudin Compared to Heparin as the Primary Anticoagulant in Pediatric Berlin Heart Recipients
Freniere et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)
Added to ASH registry: 2026-05-29
Bivalirudin Superiority in Pediatric Berlin Hearts: Too Early to Draw Conclusions?
Seelhammer et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)
Added to ASH registry: 2026-05-29
Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study
Tong et al. · The International journal of artificial organs
Added to ASH registry: 2026-05-29
Editorial: Bivalirudin with post-procedural infusion: Should the Guidelines change to keep up with the data?
Lipinski · Cardiovascular revascularization medicine : including molecular interventions
Added to ASH registry: 2026-05-29
Functionalization of PCL-based nanofibers loaded with hirudin as blood contact materials
Zheng et al. · Biomaterials advances
Added to ASH registry: 2026-05-29
Impact of Bivalirudin on Patients with Acute Coronary Syndrome Undergoing Rotational Atherectomy in Real-Life Setting: A Retrospective Cohort Study
Li et al. · Anatolian journal of cardiology
Added to ASH registry: 2026-05-29
One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention
Li et al. · Diabetes & metabolic syndrome
Added to ASH registry: 2026-05-29
One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention
Li et al. · Reviews in cardiovascular medicine
Added to ASH registry: 2026-05-29
Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis
Van der Linden et al. · British journal of clinical pharmacology
Added to ASH registry: 2026-05-29
The effect of bivalirudin on coagulation function in male patients with coronary heart disease undergoing percutaneous coronary intervention
Dequan et al. · Pakistan journal of pharmaceutical sciences
Added to ASH registry: 2026-05-29
Use of Bivalirudin for Chronic Total Occlusion Percutaneous Intervention: Insights From the PROGRESS-CTO Registry
Verreault-Julien et al. · The Journal of invasive cardiology
Added to ASH registry: 2026-05-29
Use of ecarin chromogenic assay during bivalirudin anticoagulation in adult extracorporeal membrane oxygenation
Krauter et al. · Thrombosis research
Added to ASH registry: 2026-05-29
30-Day Post-Discharge Prophylaxis with Rivaroxaban Prevents Porto-mesenteric Venous Thrombosis Following Laparoscopic Sleeve Gastrectomy
Swartz et al. · Obesity surgery
Added to ASH registry: 2026-05-28
6-(Arylaminomethyl) Isoquinolines as Enzyme Inhibitors and Their Preparation: A Patent Highlight of Factor XIIa Inhibitors
Al-Horani et al. · Cardiovascular & hematological agents in medicinal chemistry
Added to ASH registry: 2026-05-28
A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state.
Teranishi-Ikawa Y et al. · Journal of thrombosis and haemostasis : JTH
Added to ASH registry: 2026-05-28
A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism
Andersen et al. · Blood
Added to ASH registry: 2026-05-28
A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories.
Pipe et al. · Haemophilia : the official journal of the World Federation of Hemophilia
Added to ASH registry: 2026-05-28
A new strategy for anticoagulation: The factor XI inhibitors
Vedovati et al. · European journal of internal medicine
Added to ASH registry: 2026-05-28
A Non-competitive Serpin-Like Thrombin Inhibitor Isolated from Moringa oleifera Exhibit a High Affinity for Thrombin
Sawetaji et al. · The protein journal
Added to ASH registry: 2026-05-28
A Retrospective Review of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor-Related Bleedings
Hitchcock et al. · Journal of pharmacy practice
Added to ASH registry: 2026-05-28
Abelacimab in Cancer-Associated Thrombosis: The Right Drug at the Right Time for the Right Purpose. A Comprehensive Review.
Fioretti AM et al. · Reviews in cardiovascular medicine
Added to ASH registry: 2026-05-28
Acute pulmonary embolism: Diagnosis and management.
Khandait et al. · Indian heart journal
Added to ASH registry: 2026-05-28
Adherence to protocols for the use of reversal agents in patients treated with direct oral anticoagulants
Mitrovic et al. · Current medical research and opinion
Added to ASH registry: 2026-05-28
Adjunctive technologies in postoperative free-flap monitoring: a systematic review
Lacey H et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS
Added to ASH registry: 2026-05-28
Anticoagulant therapies against sepsis-induced disseminated intravascular coagulation.
Umemura et al. · Acute medicine & surgery
Added to ASH registry: 2026-05-28
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes
Hsu et al. · The New England journal of medicine
Added to ASH registry: 2026-05-28
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes
Adabag et al. · The New England journal of medicine
Added to ASH registry: 2026-05-28
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. Reply
Kirchhof et al. · The New England journal of medicine
Added to ASH registry: 2026-05-28
Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach.
Ambati et al. · Current opinion in rheumatology
Added to ASH registry: 2026-05-28
Antiphospholipid syndrome, antiphospholipid antibodies, and stroke.
Mittal et al. · International journal of stroke : official journal of the International Stroke Society
Added to ASH registry: 2026-05-28
Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management.
Knight et al. · BMJ (Clinical research ed.)
Added to ASH registry: 2026-05-28
Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis
Wang et al. · TH open : companion journal to thrombosis and haemostasis
Added to ASH registry: 2026-05-28
Apixaban and Rivaroxaban Anti-Xa Concentration Utilization in Clinical Practice
Kim et al. · Journal of cardiovascular pharmacology
Added to ASH registry: 2026-05-28
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease.
Payne et al. · Journal of the American College of Cardiology
Added to ASH registry: 2026-05-28
Apixaban for Treatment of Atrial Fibrillation and Venous Thromboembolism After Lung Transplantation
Nikodem et al. · Progress in transplantation (Aliso Viejo, Calif.)
Added to ASH registry: 2026-05-28
Showing 40 of 199. The full list is in the research library.
2022
154 articlesBivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice
Zhuang et al. · Acta pharmaceutica (Zagreb, Croatia)
Added to ASH registry: 2026-05-29
Bivalirudin in patients with ST-segment elevation myocardial infarction
Coughlan et al. · Lancet (London, England)
Added to ASH registry: 2026-05-29
Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study
Peng et al. · Frontiers in cardiovascular medicine
Added to ASH registry: 2026-05-29
Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study
Yu et al. · Frontiers in cardiovascular medicine
Added to ASH registry: 2026-05-29
Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, multicenter, intensive monitoring study
Zheng et al. · BMC cardiovascular disorders
Added to ASH registry: 2026-05-29
Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study
Li et al. · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Added to ASH registry: 2026-05-29
Efficacy and safety of bivalirudin without post-procedure infusion in patients with coronary heart disease during elective percutaneous coronary intervention: a real-world study
Wang et al. · Chinese medical journal
Added to ASH registry: 2026-05-29
Efficacy and Safety of the Reduced Bivalirudin in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention Stratified by Renal Function (REDUCE BOLUS): A Single-Blind, Stratified Randomized, Non-inferiority Trial
Hu et al. · Frontiers in cardiovascular medicine
Added to ASH registry: 2026-05-29
Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention
Li et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Added to ASH registry: 2026-05-29
Low-dose apixaban in extended treatment of cancer-associated thrombosis: Less is more?
Barca-Hernando et al. · Journal of thrombosis and haemostasis : JTH
Added to ASH registry: 2026-05-29
Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study
Li et al. · Cardiovascular therapeutics
Added to ASH registry: 2026-05-29
A Factor XIa Inhibitor Engineered from Banded Krait Venom Toxin: Efficacy and Safety in Rodent Models of Arterial and Venous Thrombosis
Chng et al. · Biomedicines
Added to ASH registry: 2026-05-28
A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation
Liuzzo et al. · European heart journal
Added to ASH registry: 2026-05-28
A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitors
Salomon et al. · Journal of thrombosis and haemostasis : JTH
Added to ASH registry: 2026-05-28
A short review of ciraparantag in perspective of the currently available anticoagulant reversal agents.
Leentjens et al. · Drug discovery today
Added to ASH registry: 2026-05-28
A systematic review and meta-analysis of dabigatran peak and trough concentration in adults
Ng et al. · British journal of clinical pharmacology
Added to ASH registry: 2026-05-28
Advances in Acute Ischemic Stroke Therapy.
Xiong Y et al. · Circulation research
Added to ASH registry: 2026-05-28
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review.
Zhu A et al. · Research and practice in thrombosis and haemostasis
Added to ASH registry: 2026-05-28
An Analysis of the Sensitivity of the Activated Partial Thromboplastin Time (APTT) Assay, as Used in a Large Laboratory Network, to Coagulation Factor Deficiencies.
Do et al. · American journal of clinical pathology
Added to ASH registry: 2026-05-28
Analysis of the Preventive Action of Rivaroxaban against Lower Extremity Deep Venous Thrombosis in Patients after Laparoscopic Radical Gastrectomy
Dong et al. · Computational and mathematical methods in medicine
Added to ASH registry: 2026-05-28
Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage
Vestal et al. · Journal of thrombosis and thrombolysis
Added to ASH registry: 2026-05-28
Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study.
Rauch et al. · Journal of clinical medicine
Added to ASH registry: 2026-05-28
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis
Costa et al. · Critical care (London, England)
Added to ASH registry: 2026-05-28
Anti-Xa Levels in Morbidly Obese Patients Using Apixaban or Rivaroxaban, Before and After Bariatric Surgery
Kok et al. · Obesity surgery
Added to ASH registry: 2026-05-28
Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury
Towers et al. · The Annals of pharmacotherapy
Added to ASH registry: 2026-05-28
Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series
Morton et al. · Journal of thrombosis and thrombolysis
Added to ASH registry: 2026-05-28
Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial
Imamura et al. · International journal of hematology
Added to ASH registry: 2026-05-28
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis
Wetmore et al. · Clinical journal of the American Society of Nephrology : CJASN
Added to ASH registry: 2026-05-28
Atraumatic splenic rupture in a patient treated with rivaroxaban: A case report and a narrative review
Labaki et al. · Clinical case reports
Added to ASH registry: 2026-05-28
Atrial Fibrillation in a Patient with Heparin-induced Thrombocytopenia Successfully Treated by Radiofrequency Catheter Ablation Using a Direct Thrombin Inhibitor
Sakai T et al. · Internal medicine (Tokyo, Japan)
Added to ASH registry: 2026-05-28
Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial.
Kawakami T et al. · The Lancet. Respiratory medicine
Added to ASH registry: 2026-05-28
Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis
Liu et al. · Pharmacological research
Added to ASH registry: 2026-05-28
Bivalirudin vs. heparin in paediatric and adult patients on extracorporeal membrane oxygenation: A meta-analysis
Li et al. · British journal of clinical pharmacology
Added to ASH registry: 2026-05-28
Catheter directed thrombolysis for deep vein thrombosis in 2022: Rationale, evidence base and future directions.
Khalid MU et al. · International journal of cardiology
Added to ASH registry: 2026-05-28
Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.
Harvey JJ et al. · The Cochrane database of systematic reviews
Added to ASH registry: 2026-05-28
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial.
Sadeghipour P et al. · JAMA cardiology
Added to ASH registry: 2026-05-28
Ciraparantag as a potential universal anticoagulant reversal agent.
Chan et al. · European heart journal
Added to ASH registry: 2026-05-28
Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects.
Ansell et al. · European heart journal
Added to ASH registry: 2026-05-28
Clonal Dissemination ofWith Binary Carriage of-Bearing Plasmids in a Chinese Hospital.
Xu Z et al. · Frontiers in microbiology
Added to ASH registry: 2026-05-28
Comparison of Interrupted and Uninterrupted Anticoagulation Therapy for Patients With Atrial Fibrillation Undergoing Catheter Ablation: A Meta-Analysis.
Jamil S et al. · Cureus
Added to ASH registry: 2026-05-28
Showing 40 of 154. The full list is in the research library.
Earlier
2142 articles (pre-2022)Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism
Houghton et al. · Mayo Clinic proceedings
Added to ASH registry: 2026-05-29
Effects of Bivalirudin and Unfractionated Heparin on Liver and Renal Function in Chinese Patients with Coronary Artery Disease Undergoing Coronary Angiography with/without Percutaneous Coronary Intervention
Jia et al. · Journal of clinical and translational hepatology
Added to ASH registry: 2026-05-29
Evaluation of Bivalirudin-Associated Major Adverse Cardiac and Hemorrhagic Events in Acute Coronary Syndrome Patients on Chronic Dialysis Following Percutaneous Coronary Intervention
Fu et al. · The Journal of invasive cardiology
Added to ASH registry: 2026-05-29
Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study
Li et al. · Frontiers in cardiovascular medicine
Added to ASH registry: 2026-05-29
Safety and Effectiveness of Bivalirudin for Perioperative Anticoagulation in a Patient With Hemophilia A Undergoing Percutaneous Coronary Intervention
Luo et al. · The American journal of the medical sciences
Added to ASH registry: 2026-05-29
Safety of Apixaban for Cancer-Associated Thrombosis
Bikdeli et al. · Thrombosis and haemostasis
Added to ASH registry: 2026-05-29
2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Douxfils et al. · Thrombosis and haemostasis
Added to ASH registry: 2026-05-28
A comprehensive appraisal of dabigatran etexilate clinical evidence and applications: a 10-year-long story
Romiti et al. · Future cardiology
Added to ASH registry: 2026-05-28
A direct thrombin inhibitor, dabigatran etexilate protects from renal fibrosis by inhibiting protease activated receptor-1
Saifi et al. · European journal of pharmacology
Added to ASH registry: 2026-05-28
A meta-analysis and cost-minimization analysis of bivalirudin versus heparin in high-risk patients for percutaneous coronary intervention
Sun et al. · Pharmacology research & perspectives
Added to ASH registry: 2026-05-28
A Meta-analysis of Clinical Trials Evaluating the Impact of Bivalirudin-based Anticoagulation for Primary Percutaneous Coronary on Long-Term Mortality
Jagadish et al. · Journal of cardiovascular pharmacology
Added to ASH registry: 2026-05-28
A rechargeable anti-thrombotic coating for blood-contacting devices.
Ham et al. · Biomaterials
Added to ASH registry: 2026-05-28
A synergy of liquid chromatography with high-resolution mass spectrometry and coagulation test for determination of direct oral anticoagulants for clinical and toxicological purposes
Maier et al. · Biomedical chromatography : BMC
Added to ASH registry: 2026-05-28
A systematic review of apixaban in prevention and treatment of cancer-associated venous thromboembolism
Caputo et al. · Journal of the American Pharmacists Association : JAPhA
Added to ASH registry: 2026-05-28
Abelacimab and factor XI inhibition: a novel mechanism for the prevention of venous thromboembolism
Narducci et al. · European heart journal
Added to ASH registry: 2026-05-28
Abelacimab for Prevention of Venous Thromboembolism
Verhamme et al. · The New England journal of medicine
Added to ASH registry: 2026-05-28
Abelacimab for Prevention of Venous Thromboembolism
Wang. · The New England journal of medicine
Added to ASH registry: 2026-05-28
Abelacimab for Prevention of Venous Thromboembolism
Toom et al. · The New England journal of medicine
Added to ASH registry: 2026-05-28
Abelacimab for Prevention of Venous Thromboembolism
Gallagher. · The New England journal of medicine
Added to ASH registry: 2026-05-28
Abelacimab for Prevention of Venous Thromboembolism. Reply
Weitz et al. · The New England journal of medicine
Added to ASH registry: 2026-05-28
Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A Review.
Ross et al. · Chest
Added to ASH registry: 2026-05-28
Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
Grossmann · International journal of molecular sciences
Added to ASH registry: 2026-05-28
Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
Lakkireddy D et al. · Circulation
Added to ASH registry: 2026-05-28
Andexanet Alfa for Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: Does a Specific Reversal Agent Justify Its Cost?.
Patel et al. · Neurology
Added to ASH registry: 2026-05-28
Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis.
Nederpelt et al. · Critical care medicine
Added to ASH registry: 2026-05-28
Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent.
Levy et al. · Journal of cardiothoracic and vascular anesthesia
Added to ASH registry: 2026-05-28
AngioJet Thrombectomy Versus Catheter-Directed Thrombolysis for Lower Extremity Deep Vein Thrombosis: A Meta-Analysis of Clinical Trials.
Li GQ et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Added to ASH registry: 2026-05-28
Anticoagulation for COVID-19 Patients: A Bird's-Eye View
Kreidieh et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Added to ASH registry: 2026-05-28
Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.
Raina et al. · Pediatric nephrology (Berlin, Germany)
Added to ASH registry: 2026-05-28
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.
Stevens et al. · Chest
Added to ASH registry: 2026-05-28
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome undergoing percutaneous coronary intervention; insights from a meta-analysis.
Kuno et al. · Coronary artery disease
Added to ASH registry: 2026-05-28
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer.
Agnelli G et al. · Thrombosis and haemostasis
Added to ASH registry: 2026-05-28
Apixaban in low-weight patients with cancer-associated thrombosis: A cross sectional study of drug levels.
Bravo Villa V et al. · Research and practice in thrombosis and haemostasis
Added to ASH registry: 2026-05-28
Argatroban Anticoagulation for Adult Extracorporeal Membrane Oxygenation: A Systematic Review
Geli J et al. · Journal of intensive care medicine
Added to ASH registry: 2026-05-28
Argatroban Versus Bivalirudin in the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia
Duewell et al. · Journal of pharmacy practice
Added to ASH registry: 2026-05-28
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.
Connell et al. · Blood advances
Added to ASH registry: 2026-05-28
Baveno VII - Renewing consensus in portal hypertension.
de Franchis et al. · Journal of hepatology
Added to ASH registry: 2026-05-28
Binding of direct oral anticoagulants to the FA1 site of human serum albumin
De Simone et al. · Journal of molecular recognition : JMR
Added to ASH registry: 2026-05-28
Bivalirudin for the prevention of hepatic artery thrombosis in pediatric liver transplantation
Craig-Schapiro et al. · Pediatric transplantation
Added to ASH registry: 2026-05-28
Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study.
Hu Y et al. · Medicine
Added to ASH registry: 2026-05-28
Showing 40 of 2142. The full list is in the research library.